Loading…
BioHarvest Sciences Inc. Common Stock is projected to decline to $2.71 by 2027, a -3% move from its current price of $2.78. BHST is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.71 | $2.78 | $2.85 | -0.02% |
| Jul 14 | $2.69 | $2.78 | $2.88 | -0.03% |
| Jul 15 | $2.66 | $2.78 | $2.90 | -0.05% |
| Jul 16 | $2.65 | $2.78 | $2.92 | -0.07% |
| Jul 17 | $2.63 | $2.78 | $2.93 | -0.09% |
| Jul 18 | $2.62 | $2.78 | $2.95 | -0.10% |
| Jul 19 | $2.60 | $2.78 | $2.96 | -0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.60 | $2.78 | $2.96 | -0.12% |
| Week 2 | $2.53 | $2.77 | $3.04 | -0.24% |
| Week 3 | $2.48 | $2.77 | $3.10 | -0.36% |
| Week 4 | $2.43 | $2.77 | $3.15 | -0.48% |
| Week 5 | $2.39 | $2.76 | $3.19 | -0.60% |
| Week 6 | $2.36 | $2.76 | $3.23 | -0.72% |
| Week 7 | $2.33 | $2.76 | $3.27 | -0.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients, and it is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions.
The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules.
The company is based in Vancouver, Canada.
BioHarvest Sciences Inc. common stock (BHST) is currently priced at $2.91, with a market capitalization of $65.96M and a market rank of 4,444. The stock trade and market position reflect its niche within the consumer defensive space as described in its segment structure and product lines.
A major floor 28.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 40.3% above — a clean break opens room to run.
A major ceiling 64.4% above — clearing it would confirm fresh momentum.
Key BHST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.84 | Sell | $2.82 | Sell |
| MA 10 | $2.84 | Sell | $2.87 | Sell |
| MA 20 | $2.99 | Sell | $3.00 | Sell |
| MA 50 | $3.49 | Sell | $3.40 | Sell |
| MA 100 | $3.93 | Sell | $3.99 | Sell |
| MA 200 | $5.60 | Sell | $4.88 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.01 | Neutral |
| Stoch RSI (14) | 66.46 | Neutral |
| CCI (20) | -76.30 | Neutral |
| Williams %R (14) | -91.43 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -10.32 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 8.57 | Buy |
| TRIX (15) | -0.94 | Sell |
| Awesome (5,34) | -0.39 | Sell |
| Ultimate (7,14,28) | 31.65 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 2.80 | Sell |
| ADX (14) | 34.27 | Sell |
| ATR (14) | 0.07 | Info |
Technical picture in the near term is NEUTRAL, with RSI14 at 30. The 50-day simple moving average is $3.82 and the 200-day simple moving average is $5.90. The stock sits near support at $2.91 and faces resistance at $4.16. The 30-day range runs from $2.40 to $3.53, and annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.75 | $2.78 | $3.29 | 0% | Neutral | |
| $2.18 | $2.71 | $3.55 | -3% | Neutral | |
| $2.25 | $2.86 | $3.88 | +3% | Neutral | |
| $2.55 | $3.32 | $4.62 | +20% | Neutral | |
| $2.68 | $3.55 | $5.05 | +28% | Bullish | |
| $2.70 | $3.63 | $5.26 | +31% | Bullish | |
| $2.78 | $3.80 | $5.60 | +37% | Bullish | |
| $2.62 | $3.62 | $5.43 | +30% | Bullish | |
| $2.72 | $3.82 | $5.81 | +37% | Bullish | |
| $3.22 | $4.58 | $7.06 | +65% | Bullish | |
| $3.76 | $5.67 | $9.25 | +104% | Bullish | |
| $5.86 | $9.73 | $17.25 | +250% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.75 | $2.78 | $3.37 | +0.00% |
| August 2026 | $2.41 | $2.84 | $3.42 | +1.99% |
| September 2026 | $2.31 | $2.74 | $3.33 | -3.48% |
| October 2026 | $2.27 | $2.71 | $3.32 | -1.13% |
| November 2026 | $2.28 | $2.72 | $3.37 | +0.61% |
| December 2026 | $2.20 | $2.64 | $3.29 | -2.84% |
Click any year to see its month-by-month BHST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BioHarvest Sciences Inc. Common Stock's 2026 outlook centres on $2.78, within a $2.75 to $3.29 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BHST could reach as high as $3.55, with a base case around $2.71 and support toward $2.18 — roughly -3% from $2.78. A consolidation phase looks the most probable path here.
Expect BHST to range from $2.25 to $3.88 through 2028. The $2.86 average target implies a +3% move from current prices. That is up +6% on the projected 2027 average. Price action looks broadly range-bound.
The BHST price prediction for 2029 points to an average of $3.32 (low $2.55, high $4.62) — a potential gain of +20% on today's $2.78. A consolidation phase looks the most probable path here.
In 2030, BHST is projected to trade between $2.68 and $5.05, averaging $3.55 — a potential gain of +28% from today's $2.78. That is up +7% on the projected 2029 average. Momentum favours further upside here.
BioHarvest Sciences Inc. Common Stock's 2031 outlook centres on $3.63, within a $2.70 to $5.26 range. That is up +2% on the projected 2030 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BHST could reach as high as $5.60, with a base case around $3.80 and support toward $2.78 — roughly +37% from $2.78. Momentum favours further upside here.
Expect BHST to range from $2.62 to $5.43 through 2033. The $3.62 average target implies a +30% move from current prices. That is -5% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The BHST price prediction for 2034 points to an average of $3.82 (low $2.72, high $5.81) — a potential gain of +37% on today's $2.78. Momentum favours further upside here.
In 2035, BHST is projected to trade between $3.22 and $7.06, averaging $4.58 — a potential gain of +65% from today's $2.78. That is up +20% on the projected 2034 average. Buyers look set to stay in control over this stretch.
BioHarvest Sciences Inc. Common Stock's 2040 outlook centres on $5.67, within a $3.76 to $9.25 range. That is up +24% on the projected 2035 average. That marks a +104% change versus current levels. Momentum favours further upside here.
By 2050, BHST could reach as high as $17.25, with a base case around $9.73 and support toward $5.86 — roughly +250% from $2.78. Buyers look set to stay in control over this stretch.
Investing $1,000 in BHST today (≈ 359.71223 BHST) could be worth
$3,500.79
+$2,500.79 (+250%) by 2050 · US Dollar
Based on the average projected BHST price of $9.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHSTwould be worth at today's price.
$1,000 invested in BHST on Jul 10, 2025 (≈ 138.504159 BHST) would be worth
$385.04
-$614.96 (-61.5%) today · 0.39× · US Dollar
Based on a BHST entry price of $7.22 vs. today's $2.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.87 | $968.64 | -3.1% |
| 1 month ago | $3.09 | $899.68 | -10.0% |
| 3 months ago | $4.31 | $645.01 | -35.5% |
| 6 months ago | $5.05 | $549.95 | -45.0% |
| 1 year ago | $7.22 | $385.04 | -61.5% |
| All time (5.0y) ago | $11.13 | $249.78 | -75.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHST forecast.
Our base-case forecast reaches $5.60 around 2040.
Implied market cap at $5.60: $126.94M
The multi-year forecast shows a bullish trajectory into later years. In 2030, the average price is projected at $3.81 with a max of $5.62 and a return on investment of 30.9%, with a bullish sentiment. By 2040, the average is forecast at $5.89 with a max of $10.17 and a ROI of 102.4%, still indicating bullish momentum.
By 2050, the average is $9.84 with a max of $18.65 and a ROI of 238.2%, with continued bullish sentiment. These figures illustrate an upward path over the long horizon, though they remain estimates and are not guarantees.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $3.81 with a maximum of $5.62 and a ROI of 30.9%, with a BULLISH sentiment.
In the near term, the outlook is NEUTRAL (2026 avg $2.91, ROI 0%). Looking further out, the forecast shows substantial upside by 2030–2050, with ROI reaching 30.9% in 2030 and up to 238.2% by 2050, all within a bullish context.
Yes. The 2040 forecast lists a max of $10.17, with an average of $5.89 and ROI of 102.4%, indicating a path that could intersect the $10 level in that year.
The RSI14 is 30, indicating a neutral near-term stance. The price trades below the SMA50 of $3.82 and well below the SMA200 of $5.90, with support at $2.91 and resistance at $4.16. The 30-day range is $2.40 to $3.53, and volatility is 60% annually.
For 2050, the average price is forecast at $9.84 with a max of $18.65 and a ROI of 238.2%, with a bullish sentiment.
BioHarvest Sciences Inc. Common Stock Community Discussion
0Share your BioHarvest Sciences Inc. Common Stock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.